Spots Global Cancer Trial Database for Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery
Official Title: Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery
Study ID: NCT04490668
Interventions
Study Description
Brief Summary: We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Detailed Description: Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increases the overall burden of patients and hospital resources. Postoperative mortality is higher in patients with anastomotic leakage. Human albumin is routinely administered after surgery with a unproven hypothesis that the human albumin is beneficial to prevent anastomotic leakage. We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Birendra K Sah, PH D
Affiliation: Ruijin Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Chen Li, PH D
Affiliation: Ruijin Hospital
Role: STUDY_DIRECTOR
Name: Zhenggang Zhu, PH D
Affiliation: Ruijin Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
